The protective effects of Pimavanserin against cerebral ischemia-induced brain injury

References

• Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–151.
   PubMed Web of Science ®Google Scholar
• Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med. 2008;14:731–737.
   PubMed Web of Science ®Google Scholar
• Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;15(3):CD000024.  doi: 10.1002/14651858.CD000024.pub4.
   PubMed Web of Science ®Google Scholar
• Kaviarasi S, Yuba E, Harada A. Krishnan UM Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia. J Control Release. 2019;300:22–45.
   PubMed Web of Science ®Google Scholar
• Han J, Tang H, Yao LF, et al. Azilsartan protects against hyperglycemia-induced hyperpermeability of the blood-brain barrier. Bioengineered. 2020;12(1):3621–3633.
   Web of Science ®Google Scholar
• Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25.
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16:1–13.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res. 1999;842:92–100.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Yanai H, Namiki Y, et al. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 2006;12:9–20.
   PubMedGoogle Scholar
• Vorbrodt AW, Dobrogowska DH. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem Cytobiol. 2004;42:67–75.
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cell-cell junctions: how to “open” the blood brain barrier. Curr Neuropharmacol. 2008;6:179–192.
   PubMed Web of Science ®Google Scholar
• Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38:323–337.
   PubMed Web of Science ®Google Scholar
• Liu J, Jin X, Liu KJ, et al. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32:3044–3057.
   PubMed Web of Science ®Google Scholar
• Thal SC, Luh C, Schaible EV, et al. Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury. PLoS One. 2012;7:e50752.
   PubMed Web of Science ®Google Scholar
• Kianirad Y, Simuni T. Pimavanserin, a novel antipsychotic for management of Parkinson’s disease psychosis. Expert Rev Clin Pharmacol. 2017;10:1161–1168.
   PubMed Web of Science ®Google Scholar
• Lavigne EG, Buttigieg D, Steinschneider R, et al. Pimavanserin promotes trophic factor release and protects cultured primary dopaminergic neurons exposed to MPP+ in a GDNF-dependent manner. ACS Chem Neurosci. 2021;12:2088–2098.
   PubMed Web of Science ®Google Scholar
• Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26:627–634. discussion 35.
   PubMed Web of Science ®Google Scholar
• Trout JJ, Koenig H, Goldstone AD, et al. Blood-brain barrier breakdown by cold injury. Polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab Invest. 1986;55:622–631.
   PubMed Web of Science ®Google Scholar
• Deng ZY, Manz DH, Torti SY, et al. Effects of ferroportin-mediated iron depletion in cells representative of different histological subtypes of prostate cancer. Antioxid Redox Signal. 2019;30(8):1043–1061.
   PubMed Web of Science ®Google Scholar
• Huang LX, Zhao B, Li QX, et al. Ephedrine alleviates middle cerebral artery occlusion-induced neurological deficits and hippocampal neuronal damage in rats by activating PI3K/AKT signaling pathway. Bioengineered. 2021;12(1):4136–4149.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1):972–983.
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653–660.
   PubMed Web of Science ®Google Scholar
• Sun B, Ou H, Ren F, et al. Propofol inhibited autophagy through Ca(2+)/CaMKKbeta/AMPK/mTOR pathway in OGD/R-induced neuron injury. Mol Med. 2018;24:58.
   PubMed Web of Science ®Google Scholar
• Sun R, Ge L, Cao Y, et al. MiR-429 regulates blood-spinal cord barrier permeability by targeting Kruppel-like factor 6. Biochem Biophys Res Commun. 2020;525:740–746.
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173–185.
   PubMed Web of Science ®Google Scholar
• Lv J, Hu W, Yang Z, et al. Focusing on claudin-5: a promising candidate in the regulation of BBB to treat ischemic stroke. Prog Neurobiol. 2018;161:79–96.
   PubMed Web of Science ®Google Scholar
• Zuo X, Lu J, Manaenko A, et al. MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice. Exp Neurol. 2019;316:12–19.
   PubMed Web of Science ®Google Scholar
• Lopez MS, Vemuganti R. Modeling transient focal ischemic stroke in rodents by intraluminal filament method of middle cerebral artery occlusion. Methods Mol Biol. 2018;1717:101–113.
   PubMedGoogle Scholar
• Yang J, Yan H, Li S, et al. Berberine ameliorates MCAO induced cerebral ischemia/reperfusion injury via activation of the BDNF-TrkB-PI3K/Akt Signaling Pathway. Neurochem Res. 2018;43:702–710.
   PubMed Web of Science ®Google Scholar
• Schulze C, Firth JA. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. J Cell Sci. 1993;104(Pt 3):773–782.
   PubMedGoogle Scholar
• Kojima T, Yamamoto T, Murata M, et al. Regulation of the blood-biliary barrier: interaction between gap and tight junctions in hepatocytes. Med Electron Microsc. 2003;36:157–164.
   PubMedGoogle Scholar
• Otani T, Furuse M. Tight Junction Structure and Function Revisited. Trends Cell Biol. 2020;30:805–817.
   PubMed Web of Science ®Google Scholar
• Krause G, Winkler L, Mueller SL, et al. Structure and function of claudins. Biochim Biophys Acta. 2008;1778:631–645.
   PubMed Web of Science ®Google Scholar
• Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93:525–569.
   PubMed Web of Science ®Google Scholar
• Ma J, Yao Y, Wang P, et al. MiR-181a regulates blood-tumor barrier permeability by targeting Kruppel-like factor 6. J Cereb Blood Flow Metab. 2014;34:1826–1836.
   PubMed Web of Science ®Google Scholar
• Dukhinova M, Kuznetsova I, Kopeikina E, et al. Platelets mediate protective neuroinflammation and promote neuronal plasticity at the site of neuronal injury. Brain Behav Immun. 2018;74:7–27.
   PubMed Web of Science ®Google Scholar
• Cloutier N, Allaeys I, Marcoux G, et al. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Natl Acad Sc USA. 2018;115:E1550–E1559.
   PubMed Web of Science ®Google Scholar
• Chollet F, Rigal J, Marque P, et al. Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke. Curr Neurol Neurosci Rep. 2018;18(12):100.
   PubMed Web of Science ®Google Scholar